Ignite Creation Date:
2024-05-06 @ 7:45 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02593487
Status:
UNKNOWN
Last Update Posted:
2015-11-03
First Post:
2015-10-29
Brief Title:
Effect of Rosuvastatin Therapy on HDL2 Level
Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization Data
Organization:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Class:
OTHER
Study ID:
ESR-14-10333
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Xu-kai Wang
Responsible Party Title:
MDPhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |